Literature DB >> 8016457

Effect of vitamin A treatment on the prolongation of dark adaptation in Stargardt's dystrophy.

A M Glenn1, G A Fishman, L D Gilbert, D J Derlacki.   

Abstract

BACKGROUND: Prolongation in recovery of rod thresholds has been demonstrated in Stargardt's dystrophy. One possible explanation for this finding includes an impairment of vitamin A transport by the retinal pigment epithelium (RPE). By delivering an increased amount of vitamin A to the RPE, it might be possible to overcome a relative deficiency of vitamin A utilization or transport, and thus improve rod dark adaptation.
METHODS: Baseline dark-adapted rod final thresholds were measured for five patients with Stargardt's dystrophy after 60 minutes of dark adaptation. A full dark-adaptation curve was then measured after exposure to a bleaching light for 5 minutes. Time of recovery to within 0.2 log units of the prebleach dark-adapted rod threshold was determined. Each subject then took a 14- to 18-day course of oral vitamin A, 50,000 IU daily. Dark adaptation was then reassessed using the same pretreatment protocol.
RESULTS: Before treatment, all five patients had a prolongation of their rod recovery curve. There was no statistically significant difference between subjects in mean time taken to reach prebleach rod baseline thresholds before and after vitamin A treatment.
CONCLUSIONS: These findings do not rule out the possibility that a delay in rod dark adaptation in Stargardt's dystrophy results from an inability to transport vitamin A from the RPE to photoreceptor cells. Nevertheless, a high dose of oral vitamin A taken for at least 14 days did not provide any objective improvement in dark-adaptation function in five such patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016457     DOI: 10.1097/00006982-199401000-00006

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p.

Authors:  K L Anderson; L Baird; R A Lewis; A C Chinault; B Otterud; M Leppert; J R Lupski
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

2.  Autosomal Dominant Retinal Dystrophies Caused by a Founder Splice Site Mutation, c.828+3A>T, in PRPH2 and Protein Haplotypes in trans as Modifiers.

Authors:  Suma P Shankar; Dianna K Hughbanks-Wheaton; David G Birch; Lori S Sullivan; Karen N Conneely; Sara J Bowne; Edwin M Stone; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-02       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.